Riggs Asset Managment Co. Inc. Acadia Pharmaceuticals Inc Transaction History

Riggs Asset Managment Co. Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 29, 2021	SELL	$41.04 - $56.79 $690,292 - $955,207	-16,820 Reduced 96.28%	650 $35,000
Q3 2020 Oct 13, 2020	BUY	$36.42 - $57.0 $612,584 - $958,740	16,820 Added 2587.69%	17,470 $2.03 Million
Q3 2017 Oct 30, 2017	BUY	$29.49 - $38.37 $19,168 - $24,940	650	650 $24,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.65B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Riggs Asset Managment Co. Inc., based on Form 13F filings with the SEC.

Stay updated on Riggs Asset Managment Co. Inc. with notifications on news.